Literature DB >> 22296677

Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic review.

D T Bradley1, T W Bourke, D J Fairley, R Borrow, M D Shields, I S Young, P F Zipfel, A E Hughes.   

Abstract

Invasive infection caused by Neisseria meningitidis is a worldwide public health problem. Previous reports have indicated that carriage of common 'defective' structural polymorphisms of the host mannose-binding lectin gene (MBL2) greatly increases an individual's risk of developing the disease. We report the largest case-control study so far to investigate the effect of these polymorphisms in meningococcal disease (296 PCR-positive cases and 5196 population controls, all of European ancestry) and demonstrate that no change in risk is associated with the polymorphisms overall or in any age-defined subgroup. This finding contrasts with two smaller studies that reported an increase in risk. A systematic review of all studies of MBL2 polymorphisms in people of European ancestry published since 1999, including 24,693 individuals, revealed a population frequency of the combined 'defective'MBL2 allele of 0.230 (95% confidence limits: 0.226-0.234). The past reported associations of increased risk of meningococcal disease were because of low 'defective' allele frequencies in their study control populations (0.13 and 0.04) that indicate systematic problems with the studies. The data from our study and all other available evidence indicate that MBL2 structural polymorphisms do not predispose children or adults to invasive meningococcal disease.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296677     DOI: 10.1111/j.1744-313X.2012.01095.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  7 in total

1.  Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein.

Authors:  Declan T Bradley; Thomas W Bourke; Derek J Fairley; Raymond Borrow; Michael D Shields; Peter F Zipfel; Anne E Hughes
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

2.  A Case-Control Study on the Risk Factors for Meningococcal Disease among Children in Greece.

Authors:  Christos Hadjichristodoulou; George Mpalaouras; Vasiliki Vasilopoulou; Antonios Katsioulis; George Rachiotis; Kalliopi Theodoridou; Georgia Tzanakaki; Vassiliki Syriopoulou; Maria Theodoridou
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

3.  Mannose-Binding Lectin Gene, MBL2, Polymorphisms Do Not Increase Susceptibility to Invasive Meningococcal Disease in a Population of Danish Children.

Authors:  Lene F Lundbo; Henrik T Sørensen; Louise N Clausen; Mads V Hollegaard; David M Hougaard; Helle B Konradsen; Zitta Barrella Harboe; Mette Nørgaard; Thomas Benfield
Journal:  Open Forum Infect Dis       Date:  2015-09-01       Impact factor: 3.835

4.  HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions.

Authors:  David M Koelle; Anna Wald; Amalia Magaret; Lichun Dong; Mina John; Simon A Mallal; Ian James; Terri Warren; Silvana Gaudieri
Journal:  Genes Immun       Date:  2016-11-17       Impact factor: 2.676

Review 5.  Interplay Between Virulence and Variability Factors as a Potential Driver of Invasive Meningococcal Disease.

Authors:  Emilio Siena; Margherita Bodini; Duccio Medini
Journal:  Comput Struct Biotechnol J       Date:  2018-02-15       Impact factor: 7.271

6.  How many single-nucleotide polymorphisms (SNPs) must be tested in order to prove susceptibility to bacterial meningitis in children? Analysis of 11 SNPs in seven genes involved in the immune response and their effect on the susceptibility to bacterial meningitis in children.

Authors:  Ewelina Gowin; Bogna Świątek-Kościelna; Ewelina Kałużna; Ewa Strauss; Jacek Wysocki; Jerzy Nowak; Michał Michalak; Danuta Januszkiewicz-Lewandowska
Journal:  Innate Immun       Date:  2018-03-13       Impact factor: 2.680

Review 7.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.